40% OFF + FREE SHIPPING + FREE TRAINING PROGRAM ON ALL OUR STACKS!
40% OFF + FREE SHIPPING + FREE TRAINING PROGRAM ON ALL OUR STACKS!
$99.99
SR9009 (Stenabolic / SR-9009) from SARMs Army, with online ordering in Canada.
| Promo | Range | Discount |
|---|---|---|
| 40% OFF | 3 + | 40% $59.99 |
SARMs Army offers SR9009, also called Stenabolic or SR-9009, for online ordering in Canada. Check the current price, stock and quantity options above.
| Primary product name | SR9009 |
|---|---|
| Alternative name | Stenabolic |
| Scientific styling | SR-9009 |
| Research category | Synthetic circadian and metabolic research compound |
| Primary research pathway | REV-ERB signalling |
| Key research themes | Endurance, mitochondrial function, energy expenditure and circadian metabolism |
| Evidence highlighted on this page | Primary mouse and cellular studies |
Payment is by Interac e-Transfer. The delivery FAQ gives an estimated Canadian delivery time of 2–5 business days after payment. For available documentation matching your product lot, contact SARMs Army with the lot number from your bottle.
SR9009 and Stenabolic refer to the same research compound. The scientific identifier is also written as SR-9009. Although it is frequently grouped with SARMs in online catalogues, SR9009 is not a selective androgen receptor modulator and does not target the androgen receptor.
Foundational research on synthetic REV-ERB ligands characterized SR9009 as an agonist of the nuclear receptors REV-ERB-alpha and REV-ERB-beta. These receptors participate in the molecular clock and help coordinate the expression of genes involved in circadian timing, metabolism and energy use.
The compound’s endurance profile comes primarily from preclinical work on REV-ERB-alpha and skeletal muscle. A 2013 mouse study of skeletal-muscle oxidative capacity found that pharmacological activation of REV-ERB-alpha increased exercise capacity and was associated with changes in mitochondrial content, respiration and oxidative function.
This provides a scientific basis for discussing SR9009 in relation to endurance-focused research, mitochondrial function and skeletal-muscle energy systems.
An earlier study of synthetic REV-ERB ligands reported changes in circadian and metabolic gene expression in the liver, skeletal muscle and adipose tissue of mice. Under the study conditions, SR9009 was associated with increased energy expenditure, while experiments in diet-induced obese mice reported reduced fat mass and changes in metabolic markers.
Those results explain why Stenabolic is often researched in cutting and energy-metabolism contexts. They support positioning SR9009 as a metabolism- and performance-focused research compound.
REV-ERB-alpha and REV-ERB-beta are nuclear receptors that link the circadian clock with metabolic gene regulation. Early research characterized SR9009 as a synthetic REV-ERB agonist capable of changing clock-related and metabolic signalling in cells and animal models.
Later mechanistic research using cells without both REV-ERB proteins found that some cellular effects of SR9009 still occurred. The most precise description is therefore that SR9009 is widely studied as a REV-ERB modulator, with effects that may not be exclusively REV-ERB-dependent.
For current delivery information and common ordering questions, visit the SARMs Army FAQ.
Yes. SR9009 is the main research identifier, SR-9009 is an alternative styling and Stenabolic is the common catalogue name for the same compound.
No. SR9009 is commonly listed alongside SARMs, but it is not a selective androgen receptor modulator. Its research literature focuses instead on REV-ERB signalling, circadian biology and metabolism.
A mouse study linked pharmacological REV-ERB-alpha activation with increased exercise capacity and changes in skeletal-muscle mitochondrial function. This is the principal scientific basis for the compound’s endurance-research profile.
Preclinical mouse research connected synthetic REV-ERB ligands with energy expenditure, fat mass and metabolic gene expression under specific experimental conditions. These findings explain the compound’s research interest in metabolism and cutting; the cited experiments did not test direct human outcomes.
Yes. This page provides online ordering for SR9009 in Canada. Select the quantity above and use the add-to-cart button to continue to checkout.
Not necessarily. SR9009 was initially characterized as a REV-ERB agonist, while later cellular research found that some effects can occur independently of REV-ERB-alpha and REV-ERB-beta. Describing it as a compound studied in connection with REV-ERB signalling is the most precise wording.
SR9009’s REV-ERB focus differs from the PPAR-delta pathway explained on the Cardarine / GW-501516 product page. For GH, IGF-1, body-composition and sleep research, compare MK-677 / Ibutamoren, or browse the complete SARMs Army product collection.
Return to the purchase section above to buy SR9009 online in Canada.